FDA Approved: TEMBEXA — Supplemental Application (Emergent BioDefense Operations Lansing LLC)

View source ↗

Summary

FDA approved a supplemental application for TEMBEXA (brincidofovir) submitted by Emergent BioDefense Operations Lansing LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• TEMBEXA (BRINCIDOFOVIR)

Snippet

SUPPL AP for TEMBEXA (BRINCIDOFOVIR)